Cryopreserved amniotic membrane in the treatment of diabetic foot ulcers: a case series

被引:0
作者
Rodriguez Valiente, Monica [1 ,2 ]
Nicolas, Francisco J. [3 ]
Garcia-Hernandez, Ana M. [1 ]
Fuente Mora, Cristina [1 ]
Blanquer, Miguel [1 ]
Alcaraz, Patricio J. [2 ]
Almansa, Sonia [2 ]
Ruiz Merino, Guadalupe [4 ]
Dolores Lopez Lucas, Ma [1 ]
Alguero, Maria C. [1 ]
Insausti, Carmen L. [1 ]
Pinero, Antonio [2 ]
Moraleda, Jose M. [1 ]
Castellanos, Gregorio [2 ]
机构
[1] Hosp Clin Univ Virgen Arrixaca, Biomed Res Inst Murcia, Cell Therapy Unit, Inst Murciano Invest Biosanitaria,IMIB Arrixaca, El Palmer, Spain
[2] Hosp Clin Univ Virgen Arrixaca, Biomed Res Inst Murcia, Dept Gen Surg, Inst Murciano Invest Biosanitaria,IMIB Arrixaca, El Palmer, Spain
[3] Hosp Clin Univ Virgen Arrixaca, Biomed Res Inst Murcia, Inst Murciano Invest Biosanitaria, Mol Oncol & TGFB,Res Unit,IMIB Arrixaca, El Palmer, Spain
[4] Hosp Clin Univ Virgen Arrixaca, Biomed Res Inst Murcia, Inst Murciano Invest Biosanitaria, FFIS Reg Murcia,Support Res Unit,IMIB Arrixaca, El Palmer, Spain
关键词
amniotic membrane; cryopreservation; diabetic foot ulcer; wound healing; CHRONIC WOUNDS; GROWTH-FACTOR; CELLS; TRANSPLANTATION; MANAGEMENT; ALLOGRAFTS; ANGIOGENESIS; SUPPRESSION;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: The amniotic membrane (AM) is a tissue with low immunogenity and high therapeutic potential due to its anti- inflammatory, anti-fibrotic and antimicrobial effects. This paper describes the use of cryopreserved amniotic membrane allografts to treat diabetic foot ulcers (DFUs) in patients with diabetes. Method: In this case series, AM was processed to obtain a final medicinal product: cryopreserved amniotic membrane. cryopreserved AM was applied every 7-10 days until total epithelialisation of the DFUs. Results: A total of 14 patients with DFUs (median size: 12.30cm, (range: 0.52-42.5cm(2)) were treated and followed up until complete closure (median time: 20 weeks, range: 7-56 weeks). Patients received 4-40 AM applications. All patients in this study achieved complete epithelialisation of the wound. No adverse events were observed. Conclusion: AM is a feasible and safe treatment in complex DFUs. Furthermore, the treatment is successful in achieving epithelialisation of long-evolution, unhealed wounds resistant to conventional therapies.
引用
收藏
页码:806 / 815
页数:10
相关论文
共 47 条
[1]   Amniotic Membrane Modifies the Genetic Program Induced by TGFβ, Stimulating Keratinocyte Proliferation and Migration in Chronic Wounds [J].
Alcaraz, Antonia ;
Mrowiec, Anna ;
Luisa Insausti, Carmen ;
Bernabe-Garcia, Angel ;
Maria Garcia-Vizcaino, Eva ;
Concepcion Lopez-Martinez, Maria ;
Monfort, Asuncion ;
Izeta, Ander ;
Maria Moraleda, Jose ;
Castellanos, Gregorio ;
Jose Nicolas, Francisco .
PLOS ONE, 2015, 10 (08)
[2]   Amniotic Membrane Transplantation in the Treatment of Chronic Lower Limb Ulcers [J].
Alsina-Gibert, M. ;
Pedregosa-Fauste, S. .
ACTAS DERMO-SIFILIOGRAFICAS, 2012, 103 (07) :608-613
[3]   Wound management of chronic diabetic foot ulcers: From the basics to regenerative medicine [J].
Andrews, Karen L. ;
Houdek, Matthew T. ;
Kiemele, Lester J. .
PROSTHETICS AND ORTHOTICS INTERNATIONAL, 2015, 39 (01) :29-39
[4]   The molecular biology of chronic wounds and delayed healing in diabetes [J].
Blakytny, R. ;
Jude, E. .
DIABETIC MEDICINE, 2006, 23 (06) :594-608
[5]  
Mompo JIB, 2011, REV ESP QUIM, V24, P233
[6]  
Datta Himadri, 2004, J Indian Med Assoc, V102, P726
[7]  
Dunford C, 1999, J Wound Care, V8, P506
[8]  
Eskandarlou M, 2016, WORLD J PLAST SURG, V5, P39
[9]   The clinical applications of human amnion in plastic surgery [J].
Fairbairn, N. G. ;
Randolph, M. A. ;
Redmond, R. W. .
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2014, 67 (05) :662-675
[10]   Dehydrated amniotic membrane allografts for the treatment of chronic wounds: a case series [J].
Forbes, J. ;
Fetterolf, D. E. .
JOURNAL OF WOUND CARE, 2012, 21 (06) :290-+